Sponsor:
Oncotherapeutics
Code:
NCT06115135
Conditions
Multiple Myeloma in Relapse
Multiple Myeloma, Refractory
Eligibility Criteria
Sex: All
Age: 0+
Healthy Volunteers: Not accepted
Interventions
Venetoclax
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-10. This information was provided to ClinicalTrials.gov by Oncotherapeutics on 2025-01-16.